Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review.

Walsh, Zach; Mollaahmetoglu, Ozden Merve; Rootman, Joseph; Golsof, Shannon; Keeler, Johanna; Marsh, Beth; Nutt, David J; Morgan, Celia J A

Walsh, Zach; Mollaahmetoglu, Ozden Merve; Rootman, Joseph; Golsof, Shannon; Keeler, Johanna; Marsh, Beth; Nutt, David J; Morgan, Celia J A.

Afiliación

Walsh Z; Department of Psychology, University of British Columbia, Canada.
Mollaahmetoglu OM; Psychopharmacology and Addiction Research Centre, Department of Psychology, University of Exeter, UK.
Rootman J; Department of Psychology, University of British Columbia, Canada.
Golsof S; Department of Psychology, University of British Columbia, Canada.
Keeler J; Eating Disorders Research Group, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, UK.
Marsh B; Psychopharmacology and Addiction Research Centre, Department of Psychology, University of Exeter, UK; and Clinical Psychopharmacology Unit, Department of Clinical, Educational and Health Psychology, University College London, UK.
Nutt DJ; Drug Science, UK; and Neuropsychopharmacology Unit, Division of Psychiatry, Department of Brain Sciences, Imperial College London, UK.
Morgan CJA; Psychopharmacology and Addiction Research Centre, Department of Psychology, University of Exeter, UK.

BJPsych Open ; 8(1): e19, 2021 12 23.

Article en En | MEDLINE | ID: mdl-35048815

Palabras clave

Alcohol disorders; anxiety disorders; depressive disorders; ketamine; mental health disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: BJPsych Open Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google